Cadrenal Therapeutics (CVKD) PT Lowered to $13 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CVKD Hot Sheet
Price: $1.76 -5.88%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Cadrenal Therapeutics (NASDAQ: CVKD) to $13.00 (from $32.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- York Space Systems (YSS) PT Lowered to $15 at Jefferies
- argenx SE (ARGX) PT Raised to $1,095 at Truist Securities
- Parsons wins $665M Army contract for support services
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
